Simcere Pharmaceutical Group Limited (HKG:2096)
8.66
+0.26 (3.10%)
Apr 3, 2025, 4:08 PM HKT
HKG:2096 Revenue
In the year 2024, Simcere Pharmaceutical Group had annual revenue of 6.64B CNY with 0.41% growth. Simcere Pharmaceutical Group had revenue of 3.52B in the half year ending December 31, 2024, a decrease of -2.83%.
Revenue
6.64B CNY
Revenue Growth
+0.41%
P/S Ratio
3.08
Revenue / Employee
1.01M CNY
Employees
6,584
Market Cap
21.46B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.64B | 27.41M | 0.41% |
Dec 31, 2023 | 6.61B | 283.72M | 4.49% |
Dec 31, 2022 | 6.32B | 1.32B | 26.49% |
Dec 31, 2021 | 5.00B | 491.00M | 10.89% |
Dec 31, 2020 | 4.51B | -527.94M | -10.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
WuXi Biologics | 19.87B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |